Your one-stop Solution for MEDICAL LEARNING & UPDATES

hidoc_medibot hidoc_medibot

Today's Updates

Worsening Heart-Kidney-Metabolic Health May Threaten Vision

Published Date: 26 Feb 2026

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Common Epilepsy Drug Tied to Increased Glaucoma Risk

Published Date: 26 Feb 2026

Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Study Maps Extensive Disease Links Beyond Childhood Eczema

Published Date: 26 Feb 2026

Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis

Published Date: 26 Feb 2026

In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Neoadjuvant Therapy Use Rising Sharply in Cancer Care

Published Date: 26 Feb 2026

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Two Biologics Show Comparable Benefit in Uveitis

Published Date: 26 Feb 2026

Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.

Metabolic Syndrome Tied to Glaucoma Risk

Published Date: 26 Feb 2026

Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.

New Rx Option for Neuromyelitis Optica Spectrum Disorder?

Published Date: 26 Feb 2026

Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder.

Ocular Therapeutix Plunges as Modest Benefit Overshadow Trial Win Over Regeneron's Eylea

Published Date: 26 Feb 2026

Ocular Therapeutix's experimental eye drug showed superiority to Regeneron's Eylea in a key late-stage trial, but ⁠its modest advantage and higher rates of certain side...

Early Retinal Fluid Drying May Extend Injection Gaps in AMD

Published Date: 26 Feb 2026

Rapid drying of retinal fluid with faricimab injections may help identify patients with neovascular age-related macular degeneration who can safely extend time between injections.

Knowledge Hub

Oncology

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study 

A rare giant sebaceous cyst of the scalp presenting as a soft tissue tumor case study.

Oncology

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides 

Precision cancer care using theranostics and radioligand therapy enhances targeted treatment and patient outcomes.

Oncology

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization 

Explore strategies for optimizing oncology trials, enhancing recruitment, decentralization, diversity, and patient-centered care.

Oncology

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies 

Enhance cancer care with multidisciplinary strategies, supportive therapies, and patient-centered interventions for better outcomes.

Oncology

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Oncology

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Oncology

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Dr. Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Dr Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Dr. Todd Bauer and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Dr. Poonam Patil and 1 more

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot